Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meridian Bioscience Inc Reaffirms FY 2013 Guidance


Wednesday, 23 Jan 2013 07:34am EST 

Meridian Bioscience Inc reaffirmed fiscal 2013 guidance and expects net sales to be in the range of $190-$195 million and per share diluted earnings to be between $0.86-$0.91. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $190 million and EPS of $0.87 for fiscal 2013. 

Company Quote

18.24
-0.47 -2.51%
19 Sep 2014